ArticleNeoplasia (New York, N.Y.)2011

Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma.

Laura Conradt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.